1. Home
  2. GUG vs LENZ Comparison

GUG vs LENZ Comparison

Compare GUG & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guggenheim Active Allocation Fund of Beneficial Interest

GUG

Guggenheim Active Allocation Fund of Beneficial Interest

HOLD

Current Price

$15.93

Market Cap

534.9M

Sector

Finance

ML Signal

HOLD

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$13.48

Market Cap

609.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GUG
LENZ
Founded
N/A
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
534.9M
609.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
GUG
LENZ
Price
$15.93
$13.48
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$56.25
AVG Volume (30 Days)
93.7K
839.8K
Earning Date
01-01-0001
04-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$157.21
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.90
$11.48
52 Week High
$16.50
$50.19

Technical Indicators

Market Signals
Indicator
GUG
LENZ
Relative Strength Index (RSI) 50.95 41.08
Support Level $15.46 N/A
Resistance Level $16.17 $30.24
Average True Range (ATR) 0.24 0.84
MACD -0.03 0.22
Stochastic Oscillator 24.24 60.65

Price Performance

Historical Comparison
GUG
LENZ

About GUG Guggenheim Active Allocation Fund of Beneficial Interest

Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Share on Social Networks: